Exagen Inc. Common Stock XGN
$7.10
+22.20%
at last close
Market Cap$140.75 million
P/E Ratio—
Div Yield—
Volume672.6K
52-Week Range
$2.59$12.23
Analyst Ratings
- Consensus
- Buy — 7 Buy · 0 Hold · 0 Sell (7 analysts)
- Avg. Price Target
- $10.14 (+42.9% upside)
Key Stats
- Today's Range
- $5.90 – $7.19
- 50-Day Range
- $5.69 – $9.22
- 52-Week Range
- $2.59 – $12.23
- Volume
- 673K shs
- Average Volume
- 379K shs
- Market Cap
- $140.75 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.02%
- Days to Cover
- 1.00
About Exagen Inc. Common Stock
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
Related Stocks
Compare head-to-head: XGN vs NTRA·XGN vs DGX·XGN vs CAI·XGN vs GRAL
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.